Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: JAMA Intern Med. 2014 May;174(5):699–707. doi: 10.1001/jamainternmed.2014.87

Figure 3. Trends in Blood Transfusion Use Prior to End-Stage Renal Disease.

Figure 3

Figure 3

Figure 3

Panel A: Proportion of Patients Receiving Any Blood Transfusion

Panel B: Number of Blood Transfusion Days (1; 2; 3; 4+)

Note: Compared with 2003–2006, the trend lines for transfusion use or number of transfusion days accelerated significantly in 2007–2010 (P<0.001 and P=0.04, respectively).

Panel C: Adjusted Prevalence Ratios of Any Blood Transfusion Prior to End-Stage Renal Disease (Referent: 1995)

Multivariable model adjusted for age, sex, race, Medicaid (“dual”) eligibility, comorbid diabetes, estimated glomerular filtration rate and body mass index at end-stage renal disease.